Biocan Novel Respi, lyophilizate and suspension for injection
Homepage Products Veterinary products Biocan Novel Respi, lyophilizate and suspension for injection
Live attenuated intranasal vaccine against B. bronchiseptica and canine parainfluenza (kennel cough).
| type of preparative: | Vaccines |
|---|---|
| target species animals: | Dog |
Composition
Live attenuated Bordetella bronchiseptica strain MSLB 3096 108.0–109.8 CFU*
Live attenuated Canine parainfluenza Type 2 virus, strain CPiV-2 Bio 15 103.5–105.8 CCID50**
*CFU: Colony forming unit
**CCID50: Cell culture infectious dose 50%
Target species
Dogs.
Indications
Active immunisation of dogs against kennel cough from 3 weeks of age:
To reduce clinical signs and bacterial shedding after infection with Bordetella bronchiseptica.
To reduce clinical signs and viral shedding after infection with canine parainfluenza virus.
Dosage and route of administration
Intranasal instillation.
Primary vaccination
A single dose from 3 weeks of age.
Revaccination
A single dose to be given annually.
Onset of immunity
3 days after primary vaccination for Bordetella bronchiseptica.
7 days after primary vaccination for canine parainfluenza virus.
Duration of immunity
At least 12 months.
Shelf life
24 months.
After reconstitution with the solvent, use immediately.
Storage
Store and transport refrigerated at 2 °C – 8 °C.
Do not freeze.
Protect from light.
Packaging
5 vials each 1 dose of the lyophilized part and 5x 0.5 ml diluent packed in one box.
10 vials each 1 dose of the lyophilized part and 10x 0.5 ml diluent packed in one box.